Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular ScaffoldCordula Felix, Robert‐Jan van Geuns, Jiang Ming Fam et al.|JACC: Cardiovascular Interventions|2016Cited by 30
Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 monthsCordula Felix, Robert‐Jan van Geuns, Roberto Diletti et al.|EuroIntervention|2017Cited by 23
Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first studyJiang Ming Fam, Roberto Diletti, Cordula Felix et al.|EuroIntervention|2016Cited by 21
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusionsJiang Ming Fam, Roberto Diletti, Soledad Ojeda et al.|EuroIntervention|2017Cited by 16
Mid-term outcomes of the Absorb BVS versus second-generation DES: A systematic review and meta-analysisCordula Felix, Robert‐Jan van Geuns, Victor J. van den Berg et al.|PLoS ONE|2018Cited by 13